Image de couverture de livre

Therapeutic targeting of GSK‐3β activation by the tyrosine kinase RYK in pancreatic ductal adenocarcinoma with BJ‐2412, a novel sunitinib analogue

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Kiran Yadav, Prakash Chaudhary, Kalpana Ghimire, Sunil Mishra, Hyunji Lee, Dawon Bae, Jae‐Hoon Chang, Byeong‐Seon Jeong, Jung‐Ae Kim
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	British Journal of Pharmacology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A Concise and High‐Yielding Synthesis of Dechlorotrichotoxin A
par: Dawon Bae, et autres
Publié: (2025)

Discovery of a Novel Cyclobutanol Scaffold With Anti‐Inflammatory Activity and Its Modular Synthesis
par: Chhabi Lal Chaudhary, et autres
Publié: (2025)

Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma
par: Junki Fukuda, et autres
Publié: (2024)

Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
par: Zheng Wu, et autres
Publié: (2025)

Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
par: Silvana Debernardi, et autres
Publié: (2024)

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
par: Andrea Vallés‐Martí, et autres
Publié: (2024)

Spatial heterogeneity of antibody–drug conjugate targets in pancreatic ductal adenocarcinoma
par: Deema Sabtan, et autres
Publié: (2026)

Differentiating localized autoimmune pancreatitis and pancreatic ductal adenocarcinoma using endoscopic ultrasound images with deep learning
par: Hitomi Nakamura, et autres
Publié: (2024)

Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma
par: Naita Maren Wirsik, et autres
Publié: (2024)

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma
par: Hannah Mearns, et autres
Publié: (2026)

Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom‐up approach
par: Marc Hilmi, et autres
Publié: (2025)

ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma
par: Yifeng Sun, et autres
Publié: (2024)

Risk factors for suicide in patients with pancreatic ductal adenocarcinoma: A population‐based study
par: Chao Wang, et autres
Publié: (2024)

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation
par: Elena Genova, et autres
Publié: (2026)

Real‐world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications
par: Toshifumi Doi, et autres
Publié: (2024)

Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts
par: Ting Zhang, et autres
Publié: (2025)

Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma
par: Susumu Daibo, et autres
Publié: (2024)

Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
par: Qun Chen, et autres
Publié: (2024)

YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
par: Yecheng Li, et autres
Publié: (2024)

Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient‐derived xenograft models
par: Alessia Anastasia, et autres
Publié: (2025)

The impact of the California state lockdown during the COVID‐19 pandemic on management of patients with pancreatic ductal adenocarcinoma
par: Parisa Oviedo, et autres
Publié: (2024)

Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
par: Jacob E. Till, et autres
Publié: (2026)

Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression
par: Yingying Tong, et autres
Publié: (2024)

Minimally invasive determination of pancreatic ductal adenocarcinoma ( PDAC ) subtype by means of circulating cell‐free RNA
par: Martin Metzenmacher, et autres
Publié: (2024)

The inverted U‐shaped relationship between epinephrine and pancreatic ductal adenocarcinoma patients' survival with compensation of lymphocyte
par: Bing‐Xue Li, et autres
Publié: (2024)

Evaluation of fine‐needle core biopsy specimens for pancreatic ductal adenocarcinoma: Diagnostic utility and helpful histological features
par: Raul S Gonzalez, et autres
Publié: (2024)

Inhibition of PHF1 promotes ferroptosis via IRES‐dependent Snail translation regulation in pancreatic ductal adenocarcinoma
par: Yujiao Xie, et autres
Publié: (2026)

Targeting iron–sulfur cluster assembly scaffold protein as a vulnerability in KRAS‐activated pancreatic ductal adenocarcinoma
par: Huarui Cai, et autres
Publié: (2024)

Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells
par: Maria Poles, et autres
Publié: (2025)

Integration of dual‐energy CT characteristics and biomarkers: Noninvasive prediction of Ki‐67 expression in pancreatic ductal adenocarcinoma
par: Wuyang Zhang, et autres
Publié: (2026)

Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma
par: Ruimeng Yang, et autres
Publié: (2025)

ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration
par: Jennifer Kosinski, et autres
Publié: (2024)

A large language model for predicting pancreatic ductal adenocarcinoma patients from blood-derived exosomal transcriptomics data
par: Choudhury, Shubham, et autres
Publié: (2026)

Technical recommendation on multiplex MR elastography for tomographic mapping of abdominal stiffness with a focus on the pancreas and pancreatic ductal adenocarcinoma
par: Schattenfroh, Jakob, et autres
Publié: (2025)

Nrf2‐mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape
par: Tung‐Wei Hsu, et autres
Publié: (2024)

Response to “The role of adjuvant chemotherapy in management of stage I pancreatic ductal adenocarcinoma deserves independent high quality research”
par: Wooil Kwon, et autres
Publié: (2024)

Circulating cell‐free DNA methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma
par: Guochao Zhao, et autres
Publié: (2024)

Single‐cell RNA sequencing and high‐dimensional flow cytometry reveal distinct peripheral immune landscapes of type 1 autoimmune pancreatitis and pancreatic ductal adenocarcinoma
par: Chenxiao Liu, et autres
Publié: (2026)

Development of irreversible pancreatic ductal change triggered by pancreatic duct stenting in chronic pancreatitis
par: Kensuke Takuma, et autres
Publié: (2024)

Formulation breakthroughs driving broader tyrosine kinase use
par: Hans Lennernäs, et autres
Publié: (2026)